达夫尼丁通过调节炎症和内 плазма网膜压力诱导的亡来改善糖尿病心肌病症
Xiaolong Zhao1, Longqi Shang2, Chunjian Shen3
1Dalian Medical University, No. 9 West Section Lvshun South Road, Dalian 116044, P.R. China.
Experimental animals
|August 7, 2024
概括
达夫尼丁通过改善心脏功能和减少糖尿病大鼠心肌损伤,有效治疗糖尿病心肌病 (DCM). 这种天然化合物在治疗糖尿病相关心脏并发症方面表现有前途.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 达夫尼丁对糖尿病和脏问题有好处.
- 达芬尼在糖尿病心肌病 (DCM) 中的具体作用和机制尚不清楚.
研究的目的:
- 在糖尿病心肌病的小鼠模型中研究达芬尼的治疗效果和分子机制.
主要方法:
- 在使用斯特佐托 (STZ) 的老鼠中诱导糖尿病.
- 糖尿病大鼠接受了12周的达芬尼丁 (1和4毫克/千克) 或DMSO治疗.
- 评估了心脏功能,心肌病理,血糖和分子通路.
主要成果:
- 达夫尼丁剂量取决于降低高血糖水平.
- 达夫尼丁改善了心脏功能,降低了心肌损伤标志物,并抑制了糖尿病大鼠的纤维化.
- 达夫尼丁抑制了炎症,内分泌网膜压力诱导的亡,并部分阻断了糖尿病诱导的基因激活蛋白激酶通路激活.
结论:
- 达夫尼丁在治疗糖尿病心肌病症方面显示出显著的治疗潜力.
- 达夫尼丁通过抗炎和抗亡作用改善心脏功能障碍和DCM的病理变化.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Heart Failure Drugs: Diuretics
353
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
353


